Transjugular renal biopsy in high-risk patients: an American case series

<p>Abstract</p> <p>Background</p> <p>In the United States, transjugular renal biopsies using the Quickcore™ side cut needle system have previously been described primarily for transjugular renal biopsy in patients with concurrent liver and kidney disease.</p> <...

Full description

Bibliographic Details
Main Authors: Lomis Nick N, Chung Ellen M, Musio Franco M, Abbott Kevin C, Lane John D, Yuan Christina M
Format: Article
Language:English
Published: BMC 2002-07-01
Series:BMC Nephrology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2369/3/5
_version_ 1819032835500015616
author Lomis Nick N
Chung Ellen M
Musio Franco M
Abbott Kevin C
Lane John D
Yuan Christina M
author_facet Lomis Nick N
Chung Ellen M
Musio Franco M
Abbott Kevin C
Lane John D
Yuan Christina M
author_sort Lomis Nick N
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>In the United States, transjugular renal biopsies using the Quickcore™ side cut needle system have previously been described primarily for transjugular renal biopsy in patients with concurrent liver and kidney disease.</p> <p>Methods</p> <p>We describe transjugular renal biopsy with the Quickcore™ system in 9 patients with nephrotic syndrome and contraindications to percutaneous renal biopsy, who underwent biopsy between 23 October 1996 and 12 April 2001. The most common contraindication was oral anticoagulation with coumadin (40%). Other contraindications included horseshoe kidney, severe renal failure, and spontaneous coagulopathy. A 62 cm straight catheter and 60 cm side-cut Quickcore™ biopsy needle were used to obtain cortical tissue. Packing of the biopsy tract with Gelfoam™ was used for venographically identified capsular perforation.</p> <p>Results</p> <p>Ten procedures were performed on 9 patients with one requiring re-biopsy (5% of all renal biopsies performed at our institution). There were 9 transjugular renal biopsy and one combined liver-kidney biopsy. A mean of 4 ± 2 passes were made, with a mean of 3 ± 1 cores obtained per procedure. Histologic diagnosis was made in 90% of biopsies and in 100% of patients. Two patients developed transient hydronephrosis associated with gross hematuria; both required transfusion. Capsular perforation occurred in 90%. One patient died of bacterial sepsis, unrelated to the biopsy, several days after the procedure.</p> <p>Conclusions</p> <p>Transjugular renal biopsy appears to be efficacious in high-risk patients, for whom the percutaneous approach is contraindicated, including patients on oral anticoagulation. The transfusion rate in the present study was similar to other American reports using this technique.</p>
first_indexed 2024-12-21T07:08:15Z
format Article
id doaj.art-d3fb85f7c6f74641a2f8b35db3a1aa37
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-21T07:08:15Z
publishDate 2002-07-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-d3fb85f7c6f74641a2f8b35db3a1aa372022-12-21T19:12:03ZengBMCBMC Nephrology1471-23692002-07-0131510.1186/1471-2369-3-5Transjugular renal biopsy in high-risk patients: an American case seriesLomis Nick NChung Ellen MMusio Franco MAbbott Kevin CLane John DYuan Christina M<p>Abstract</p> <p>Background</p> <p>In the United States, transjugular renal biopsies using the Quickcore™ side cut needle system have previously been described primarily for transjugular renal biopsy in patients with concurrent liver and kidney disease.</p> <p>Methods</p> <p>We describe transjugular renal biopsy with the Quickcore™ system in 9 patients with nephrotic syndrome and contraindications to percutaneous renal biopsy, who underwent biopsy between 23 October 1996 and 12 April 2001. The most common contraindication was oral anticoagulation with coumadin (40%). Other contraindications included horseshoe kidney, severe renal failure, and spontaneous coagulopathy. A 62 cm straight catheter and 60 cm side-cut Quickcore™ biopsy needle were used to obtain cortical tissue. Packing of the biopsy tract with Gelfoam™ was used for venographically identified capsular perforation.</p> <p>Results</p> <p>Ten procedures were performed on 9 patients with one requiring re-biopsy (5% of all renal biopsies performed at our institution). There were 9 transjugular renal biopsy and one combined liver-kidney biopsy. A mean of 4 ± 2 passes were made, with a mean of 3 ± 1 cores obtained per procedure. Histologic diagnosis was made in 90% of biopsies and in 100% of patients. Two patients developed transient hydronephrosis associated with gross hematuria; both required transfusion. Capsular perforation occurred in 90%. One patient died of bacterial sepsis, unrelated to the biopsy, several days after the procedure.</p> <p>Conclusions</p> <p>Transjugular renal biopsy appears to be efficacious in high-risk patients, for whom the percutaneous approach is contraindicated, including patients on oral anticoagulation. The transfusion rate in the present study was similar to other American reports using this technique.</p>http://www.biomedcentral.com/1471-2369/3/5transjugular renal biopsykidneyliveranticoagulationhorseshoe kidneyrenal failure
spellingShingle Lomis Nick N
Chung Ellen M
Musio Franco M
Abbott Kevin C
Lane John D
Yuan Christina M
Transjugular renal biopsy in high-risk patients: an American case series
BMC Nephrology
transjugular renal biopsy
kidney
liver
anticoagulation
horseshoe kidney
renal failure
title Transjugular renal biopsy in high-risk patients: an American case series
title_full Transjugular renal biopsy in high-risk patients: an American case series
title_fullStr Transjugular renal biopsy in high-risk patients: an American case series
title_full_unstemmed Transjugular renal biopsy in high-risk patients: an American case series
title_short Transjugular renal biopsy in high-risk patients: an American case series
title_sort transjugular renal biopsy in high risk patients an american case series
topic transjugular renal biopsy
kidney
liver
anticoagulation
horseshoe kidney
renal failure
url http://www.biomedcentral.com/1471-2369/3/5
work_keys_str_mv AT lomisnickn transjugularrenalbiopsyinhighriskpatientsanamericancaseseries
AT chungellenm transjugularrenalbiopsyinhighriskpatientsanamericancaseseries
AT musiofrancom transjugularrenalbiopsyinhighriskpatientsanamericancaseseries
AT abbottkevinc transjugularrenalbiopsyinhighriskpatientsanamericancaseseries
AT lanejohnd transjugularrenalbiopsyinhighriskpatientsanamericancaseseries
AT yuanchristinam transjugularrenalbiopsyinhighriskpatientsanamericancaseseries